[Cl:1][C:2]1[S:3][C:4]([CH2:7][N:8]2CO[CH2:11][N:10](C)[C:9]2=[N:15][N+:16]([O-:18])=[O:17])=[CH:5][N:6]=1.[OH-].[Na+]>Cl>[Cl:1][C:2]1[S:3][C:4]([CH2:7][NH:8][C:9]([NH:10][CH3:11])=[N:15][N+:16]([O-:18])=[O:17])=[CH:5][N:6]=1A mixture of 5.0 g of 5-(2-chlorothiazol-5-ylmethyl)-3-methyl4-nitroimino-perhydro-1,3,5-oxadiazine and 20 ml of concentrated hydrochloric acid is stirred for 2 hours at 80° C. The reaction mixture is cooled to 5° C., adjusted to a pH of about 5 with concentrated caustic soda solution and filtered. The filtering residue is mixed with diethyl ether/ethyl acetate 1:1 (v:v) and filtered again. The title compound is thus obtained.